In February, the company reacquired full rights to the shot from Astellas, which paid $10 million ... GSK's existing scientific footprint in the Boston area," said GSK's R&D chief Hal Barron.

Leaders of three of these companies – Philadelphia’s Interius BioTherapeutics, Seattle’s Umoja BioPharma, and Boston’s Kelonia ... has partnered with Astellas in a similar fashion.

Currently, there is no standard treatment for these patients,” says Ian Krop, an oncologist at the Dana–Farber Cancer Institute in Boston, USA, and lead investigator of the TDM4374g trial.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The therapeutic landscape for diabetic macular edema ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Back for a second year, Winteractive features more than 15 different outdoor art installations, some interactive, some enormous, all strewn across Downtown Boston, from immersive, Instagrammable ...

Brown has missed two out of the last three games and left Boston's matchup with Brooklyn on Mar. 15 early due to back spasms. Sam Hauser will likely remain in the Celtics' starting lineup until ...

The best time to visit Boston is from June to October. Mild autumn weather makes touring around on foot a joy. And even though summer brings in swarms of tourists and expensive hotel rates ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Sanofi SA is getting deeper into oncology and immunology therapy development through buying Dren Bio Inc.’s myeloid cell engager for deep B-cell depletion, DR-0201. The deal could reach as high as ...

Opening Day may be less than two weeks away, but Red Sox manager Alex Cora ...